Source: BioPortfolio

The Medicines Company: A new cholesterollowering drug developed by MDCONews under license from Alnylam could soon be under review with the US FDA and an approval appears likely httpstwitter.comNatureBiotechstatus1202968187903582208Â

A new cholesterollowering drug developed by MDCONews under license from Alnylam could soon be under review with the US FDA and an approval appears likely httpstwitter.comNatureBiotechstatus1202968187903582208 ...

Read full article »
The Medicines Company's Competitors | The Medicines Company's News | The Medicines Company's Financials
Stay up-to-date with the latest news on The Medicines Company
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Mark Timney's photo - CEO of The Medicines Company

CEO

Mark Timney

CEO Approval Rating

88/100

Read more
Stay up-to-date with the latest news on The Medicines Company